LENHANVY Trademark

Trademark Overview


On Friday, September 16, 2022, a trademark application was filed for LENHANVY with the United States Patent and Trademark Office. The USPTO has given the LENHANVY trademark a serial number of 97595381. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, August 7, 2024. This trademark is owned by Gilead Sciences Ireland UC. The LENHANVY trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
lenhanvy

General Information


Serial Number97595381
Word MarkLENHANVY
Filing DateFriday, September 16, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2023

Trademark Statements


Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Translation of Words in MarkThe wording "LENHANVY" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events


Event DateEvent Description
Tuesday, December 20, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 20, 2022NEW APPLICATION ENTERED
Monday, October 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 12, 2022ASSIGNED TO EXAMINER
Tuesday, December 20, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 20, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, December 20, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, December 20, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, December 28, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, January 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 2, 2023SOU EXTENSION 1 FILED
Wednesday, August 2, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 7, 2024SOU EXTENSION 2 FILED
Wednesday, February 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, February 7, 2024SOU EXTENSION 2 GRANTED
Friday, February 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2024SOU EXTENSION 3 FILED
Wednesday, August 7, 2024SOU EXTENSION 3 GRANTED